Relafen and visual disturbance Patient Reports February 13, 2012
Relafen Side Effects Report #5734424-7
Relafen side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient, 70 years of age, was diagnosed with thyroid disorder, migraine
and was treated with Relafen. After drug was administered, patient experienced the following side effects: vision blurred, visual disturbance. Relafen dosage: unknown. During the same period patient was treated with LEVOTHROID, EXCEDRIN. Patient recovered.Relafen Side Effects Report #4960454-9
Relafen side effect was reported by a Pharmacist from CANADA on Mar 29, 2006. Female patient, 60 years of age, was treated with Relafen. After drug was administered, patient experienced the following side effects: retinal tear, vision blurred, visual disturbance. Relafen dosage: 500MG TWICE PER DAY. Patient recovered.
Relafen Side Effects Report #4967520-2
Relafen side effect was reported by a Pharmacist from CANADA on Mar 29, 2006. Female patient, 60 years of age, was treated with Relafen. After drug was administered, patient experienced the following side effects: retinal tear, vision blurred, visual disturbance. Relafen dosage: 500MG TWICE PER DAY. Patient recovered.
Relafen Side Effects Report #4967528-7
Relafen side effect was reported by a Pharmacist from CANADA on Mar 29, 2006. Female patient, 60 years of age, was treated with Relafen. After drug was administered, patient experienced the following side effects: retinal tear, vision blurred, visual disturbance. Relafen dosage: 500MG TWICE PER DAY. Patient recovered.
Relafen Side Effects Report #4986342-X
Relafen side effect was reported by a Pharmacist from CANADA on Mar 29, 2006. Female patient, 60 years of age, weighting 144.4 lb, was treated with Relafen. After drug was administered, patient experienced the following side effects: retinal tear, vision blurred, visual disturbance. Relafen dosage: 500MG TWICE PER DAY. During the same period patient was treated with PREVACID, SYNTHROID. Patient recovered.
Relafen and visual disturbance 